NCCN Guidelines® Insights - Soft Tissue Sarcoma, Version 1.2021
The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines.
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Sarcoma

Join Suzanne George, MD and Chandrajit P. Raut, MD, MSc from Dana-Farber Cancer Institute as they present their expertise on a range of cases pertaining to sarcoma.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Sarcoma

Join Suzanne George, MD and Chandrajit P. Raut, MD, MSc from Dana-Farber Cancer Institute as they present their expertise on a range of cases pertaining to sarcoma.

NCCN Guidelines® Insights - Gastrointestinal Stromal Tumors, Version 2.2014

Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)–activating mutations.

Imatinib-Induced Bone Edema: Case Report and Review of Literature

Imatinib mesylate represents a revolution in the management of patients with metastatic gastrointestinal stromal tumors (GISTs). More recently, postoperative imatinib has been shown to improve both disease-free and overall survival in patients with high-risk of recurrence.

Recorded Presentations from the NCCN 2012 Webinar Series: Sarcomas™: Advanced, Metastatic, and Progressive Soft Tissue Sarcomas: Current and Future Treatment Options

This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

Recorded Presentations from the NCCN 2012 Webinar Series: Sarcomas™: Management of Localized Soft Tissue Sarcomas: The Role of Neoadjuvant and Adjuvant Systemic Therapy

This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

Recorded Presentations from the NCCN 2012 Webinar Series: Sarcomas™: Systemic Therapy for the Initial Management of Bone Cancers

This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

Recorded Presentations from the NCCN 2012 Webinar Series: Sarcomas™: Bone Cancers: Management of Relapsed or Refractory Disease

This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

Recorded Presentations from the NCCN 2012 Webinar Series: Sarcomas™: Surgical Management of Soft Tissue Sarcomas

This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

Pages

Subscribe to RSS - Sarcomas